2017 Endocrine Fellows Series: Type 1 Diabetes Care and Management

Orlando, FL US

Tuesday, March 28, 2017– Rosen Centre Hotel

Wednesday, March 29, 2017– Thursday, March 30, 2017

Hyatt Regency Orlando 

The fourth annual Endocrine Fellows Series: Type 1 Diabetes Care and Management is a live CME-certified conference of pediatric and adult endocrine fellows held prior to ENDO 2017 (April 1- 4, 2017) in Orlando, FL. For details on the current and future programs, visit endocrine.org/t1dmfellows.

This activity is supported by educational grants from The Leona M. and Harry B. Helmsley Charitable Trust, Lilly USA, LLC, and Medtronic Diabetes.

Target Audience

This continuing medical education activity should be of substantial interest to pediatric and adult endocrine fellows.

Learning Objectives

Upon completion of this educational activity, participants will be able to (or better able to):

  • Differentially diagnose T1D in youth and assess the familial risk of developing T1D
  • Utilize patient education and counseling to motivate patients and their caregivers and promote adherence
  • Apply current clinical information to set appropriate blood glucose targets taking into consideration a patient’s lifestyle, age and condition
  • Evaluate clinical practice guidelines on the prevention, screening and management of comorbidities
  • Explain the neurological consequences of hypoglycemia and hyperglycemia and recognize potential causes
  • Recognize special considerations in the management of diabetes in a trauma or in-patient setting
  • Discuss the important of individualized nutrition plans and goals for patients with T1D
  • Discuss the potential risks and benefits associated with emerging therapies for diabetes

Additional Information

Target Audience: 
Physician-in-practice
Fellow
Educator/Teacher
Competency Area: 
Professionalism
Patient Care and Procedural Skills
Medical Knowledge
Practice-based Learning and Improvement
Topic Area: 
Diabetes and Glucose Metabolism
Quality Improvement and Healthcare Delivery
General Endocrinology
Pediatric Endocrinology
Level of Outcomes: 
Level 1 (Participation)
Level 2 (Satisfaction)
Level 3A (Learning: Declarative Knowledge (Knows))
Level 3B (Learning: Procedural Knowledge (Knows How))
Level 4 (Learning: Competence (Shows How))
Level 5 (Performance (Does))
Activity summary
Available credit: 
  • 16.50 AMA PRA Category 1 Credits
  • 16.50 CME Certificate of Participation
Course opens: 
03/16/2017
Course expires: 
03/31/2018
Rating: 
5
Hyatt Regency Orlando
9801 International Dr
Orlando, FL 32819
United States

Program Directors

Irl B. Hirsch, MD; University of Washington 
Linda Siminerio, PhD; University of Pittsburgh Diabetes Institute

Presenters

Timothy S. Bailey, MD; Advanced Metabolic Care and Research Institute Inc.
Roy W. Beck, MD, PhD; Jaeb Ctr for Hlth Res/University of South Florida
Bruce A. Buckingham, MD; Stanford Univ Sch of Med
Mark A. Clements,MD, PHD, CPI; Children’s Mercy Kansas City
Luisa A. Duran, MD; John Muir Health
Margaret Scarborough Eckel; Patient
Peter J. Eckel; Denver, Patient
Robert H. Eckel, MD; University of Colorado 
Alison B. Evert, MS, RD, CDE; University of Washington
Carla J. Greenbaum, MD, Benaroya Research Institute
James S. Hirsch; Author
Janet B. McGill, MD; University of Washington
William H. Polonsky, PHD, CD; Behavioral Diabetes Institute
Michael C. Riddell, PhD; York University (Canada)
Desmond A. Schatz, MD; University of Florida
Sandra I. Sobel, MD; University of Pittsburgh
Guillermo E. Umpierrez, MD, CDE; Emory University

DISCLOSURE POLICY

The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to the Endocrine Society and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the CME content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (e.g., stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers' bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent CME planners with relevant financial relationships from planning or delivery of content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion.

The Endocrine Society has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.

The faculty reported the following relevant financial relationship(s) during the content development process for this activity:

Timothy S Bailey, MD: Consultant, Bayer, BD, Calibra, Lilly, Medtronic, Novo Nordisk, sanofi; Researcher, Versartis, Yofimeter; Speaker, Insulet, Medtronic, Novo Nordisk, sanofi

Bruce A. Buckingham, MD: Advisory Board Member, Animas, Halozyme, Novo Nordisk, Sanofi; Advisory Board Member and Investigator, Convatec, Medtronic, Tandem; Investigator, Bayer, Dexcom

Mark A. Clements, MD: Advisory Group Member, Glooko/Diasend

Robert H. Eckel, MD: Consultant, Merck & Co. Novo Nordisk, Consultant; Sanofi; Independent Contractor, UniQure; Researcher, Ionis

Alison B. Evert, MS: Medical Advisory Board Member, Seseonice

Carla J. Greenbaum, MD: Consultant, Bristol-Myers Squibb, Pfizer, Inc.; Principal Investigator, Jansen Pharmaceuticals, Novo Nordisk

Irl B. Hirsch, MD: Consultant, Abbott laboratories, Roche Diagnostics, Intarcia, Valeritas

Janet B. McGill, MD: Advisory Group Member, Jansen Pharmaceuticals, Merck & Co.; Committee Member, Boehringer-Ingelheim; Speaker, Jansen Pharmaceuticals

William H. Polonsky, PhD: Consultant, Abbott Laboratories, Astra Zeneca, Dexcom, Eli Lilli & Company, Novo Nordisk, Roche Diagnostics

Guillermo E. Umpierrez, MD: Consultant, Ad Hoc, Sanofi; Principal Investigator, Astra Zeneca, Merck & Co., Sanofi

The faculty reported the no relevant financial relationship: Roy W Beck, MD; Luisa A Duran, MD; Margaret S. Eckel; Peter J. Eckel; James S. Hirsch; Michael Riddell, MD; Desmond A Schatz, MD; Sandra Sobel, MD

The Endocrine Society staff associated with the development of content for this activity reported no relevant financial relationships.

Available Credit

  • 16.50 AMA PRA Category 1 Credits
  • 16.50 CME Certificate of Participation

Accreditation Period

Course opens: 
03/16/2017
Course expires: 
03/31/2018